Browse Pharmaceutical industry topic

Evaluation subtopic

Articles 1-37 out of 37 article(s) Title Author Type Date Words Ending the Atrocities. Faloon, William Editorial Mar 1, 2009 3596 Amerilab Technologies, Inc. Company overview Mar 1, 2008 401 Alkemists Pharmaceuticals. Company overview Mar 1, 2008 325 The high costs of drug costs. Allina, Amy Sep 1, 2007 2695 McKesson Provider Technologies, Alpharetta, Ga.: rank: 9. Hagland, Mark Jun 1, 2007 590 FDA approves Gemzar. Moss, Ralph Mar 1, 2007 512 Prices soar for cancer drugs: slight increase in survival, vast increase in cost. Szabo, Liz Sep 1, 2006 750 Meeting explores pricing of pharmaceutical products. Jun 1, 2006 872 IND exemption requires all five criteria be met; DSI reports surge in consumer complaints in 2005. Pickett, Joseph May 1, 2006 872 Money proves to be real pill for industry. Feb 1, 2005 1002 La Jolla Pharmaceutical shares lose 60% of value: Artes Medical Inc. is suing drug maker Aventis for alleged patent infringement. Webb, Marion Brief Article Oct 25, 2004 249 There's no simple cure for manufacturers of vaccines. Hemphill, Allen Polk Oct 25, 2004 747 Analysts mixed on Ligand after setbacks. Webb, Marion Aug 9, 2004 534 Asia. Brief Article Jun 15, 2004 247 Weekly profile. Brief Article Jan 19, 2004 208 Local companies hard pressed to keep up in profit department. Berry, Kate Oct 6, 2003 624 'Intended use' is validation, FDA meeting told; better acceptance methods seen as key. Sami, Tamra Aug 1, 2003 912 Process validation tops warning letter citations in '02; fewer letters issued. Koprowski, Gene J. Aug 1, 2003 632 Par hit with 18-item 483 for GMP, validation deficiencies. Sami, Tamra Aug 1, 2003 804 Forest Labs fails to establish lab controls, lacks written production procedures. Gould, Dawn Aug 1, 2003 311 ANALYST INTERVIEW: OUTLOOK FOR LARGE CAP PHARMACEUTICALS: KENNETH NOVER - A.G. EDWARDS. Interview Jul 14, 2003 106 Pre-approval inspections uncover stability fluctuations. Sami, Tamra Jul 1, 2003 604 Umbilical cord clamp manufacturer fails to establish quality controls. Gould, Dawn Brief Article Jul 1, 2003 164 Biotech stock falls after poor test results: La Jolla Pharmaceutical downgraded after report on lupus drug showing. (Interface: News from the Digital World). Webb, Marion Feb 24, 2003 482 L.A. companies are popular on analysts' 'beauty' lists for 2003. (Up Front). Palazzo, Anthony Jan 20, 2003 1740 Eleven local private companies make Inc 500 list for most growth. Oct 21, 2002 415 Integrity Pharmaceutical hit for Part 11, stability. Brief Article Aug 1, 2000 250 DuPont blend uniformity, media fills cited in letter. Brief Article Aug 1, 2000 244 Blue Ridge, PDC get same letters on validation faults. Brief Article Aug 1, 2000 605 Chinese API manufacturer warned on cleaning errors. Brief Article Aug 1, 2000 205 Immunex avoids warning, but hit for OOS, processes. Brief Article Aug 1, 2000 883 Lichtenberg and Philipson. Brief Article Mar 22, 2000 178 Quintiles Transnational Ratings Raised by S&P. Oct 20, 1998 237 Pfizer Rtgs Affrmd by S&P After Share Repurch Anncmnt. Sep 24, 1998 273 Cardinal Hlth,Bergen Brunswig Outlks to Pos by S&P. Aug 25, 1997 570 Managed Care picks favorite drug companies. Feb 3, 1997 666 Financial analysts cite Johnson & Johnson as operating performance winner for pharmaceutical category in Hidden Value(TM) Study. Jul 31, 1995 379